NADAC acquisition cost data for MOVIPREP POWDER PACKET. This is a brand-name medication — generic alternatives may be available at lower prices.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 65649020175 | $121.12 | 2022-01-01 | Rx |
| 65649020175 | $121.12 | 2022-01-01 | Rx |
| 65649020175 | $121.12 | 2022-01-01 | Rx |
| 65649020175 | $121.12 | 2022-01-01 | Rx |
| 65649020175 | $121.12 | 2022-01-01 | Rx |
| 65649020175 | $121.12 | 2022-01-01 | Rx |
| 65649020175 | $121.12 | 2022-01-01 | Rx |
| 65649020175 | $121.12 | 2022-01-01 | Rx |
| 65649020175 | $121.12 | 2022-01-01 | Rx |
| 65649020175 | $121.12 | 2022-01-01 | Rx |
Generic: PEG3350/Sod Sul/NaCl/KCl/Asb/C | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $4.6M | 43,538 | 42,088 | $104.66 |
| 2020 | $991.5K | 8,773 | 8,544 | $112.05 |
| 2021 | $458.7K | 4,073 | 3,942 | $111.47 |
| 2022 | $131.2K | 1,076 | 1,026 | $119.27 |
| 2023 | $73.2K | 548 | 517 | $131.13 |
These generic drugs may be equivalent alternatives at lower prices.
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| Maryland | $19.1K | 133 | 120 |
| California | $13.4K | 95 | 95 |
| Texas | $3.8K | 30 | 30 |
| New York | $3.6K | 26 | 22 |
| Arizona | $2.5K | 19 | 14 |
| Florida | $2.1K | 16 | 16 |
| Massachusetts | $2.1K | 16 | 14 |
| Washington | $2.0K | 16 | 16 |
| Alaska | $1.8K | 17 | 17 |
| Virginia | $1.7K | 12 | 12 |
| Kentucky | $1.6K | 13 | 13 |
| Arkansas | $1.4K | 11 | 11 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.